MPG.eBooks - Description: Clinical review report: Ozenoxacin 1% cream (Ozanex) (Ferrer internacional, S.A.)

Cover Image

Read Now

Clinical review report: Ozenoxacin 1% cream (Ozanex) (Ferrer internacional, S.A.) indication : the topical treatment of impetigo in patients aged two months and older

The objective of this report is to perform a systematic review of the beneficial and harmful effects of ozenoxacin 1% cream for the topical treatment of impetigo in patients aged two months and older

Bibliographic Details
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2018, October 2018
Series:	CADTH common drug review
Subjects:	Quinolones / Therapeutic Use Child Canada Impetigo / Drug Therapy Infant Aminopyridines / Therapeutic Use Treatment Outcome
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK539436
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The objective of this report is to perform a systematic review of the beneficial and harmful effects of ozenoxacin 1% cream for the topical treatment of impetigo in patients aged two months and older
Item Description:	"Version: Final."
Physical Description:	1 PDF file (86 pages)